Traders should monitor for potential downward pressure on VERA shares, especially given the breadth and coordination of the sell-off. Consider whether this reflects profit-taking post-runup or a lack of confidence ahead of an upcoming catalyst. Watch for any follow-up filings or news.
Price Chart
Executive Summary
Seven executives at Vera Therapeutics, including the CEO and CFO, collectively sold over $1.4 million in shares on February 23, 2026, all through open-market transactions at the same price. This represents a coordinated insider selling event involving nearly the entire C-suite.
Key Financial Metrics
Key Facts
- CEO Marshall Fordyce sold 16,925 shares for $710,577.51, the largest individual transaction.
- All seven insiders executed open-market sales (Form 4 code 'S') on the same day at $41.9839 per share.
- Total value of the cluster: $1,406,042.71 across 33,490 shares sold.
- Selling executives include all key C-suite officers: CEO, CFO, CMO, COO, CCO, CRO, and SVP Finance.
- No purchases or non-cash transactions (e.g., grants, exercises) were part of this cluster.
Financial Impact
$1.41 million in insider selling over one day
Risk Factors
- Perception of insider pessimism given the complete absence of buying and participation by top leadership.
- Potential for negative market reaction due to concentration of selling among decision-makers with material non-public information.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (7 trades, 7d window) | cluster-VERA-1772067667098 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 8-K | $33.67 $34.00 | ▲ +0.98% | ▲ +0.16% | $30.13 (−10.53%) |
Aug 10, 2026 7w ago | 8-K | $30.29 $32.28 | ▲ +6.57% | ▲ +6.97% | $30.13 (−0.54%) |
Aug 10, 2026 7w ago | Press Release | $30.29 $32.28 | ▲ +6.57% | ▲ +6.97% | $30.13 (−0.54%) |
Jul 9, 2026 12w ago | 8-K | $42.45 $39.12 | ▼ −7.84% | ▼ −7.71% | $30.13 (−29.03%) |
Jul 7, 2026 12w ago | 8-K | $42.96 $43.13 | ▲ +0.40% | ▼ −0.16% | $30.13 (−29.88%) |
Jun 11, 2026 16w ago | Institutional Cluster | $33.65 $35.01 | ▲ +4.04% | ▲ +3.61% | $30.13 (−10.48%) |
Jun 2, 2026 17w ago | 8-K | $31.26 $31.81 | ▲ +1.76% | ▲ +4.72% | $30.13 (−3.63%) |
Jun 2, 2026 17w ago | Press Release | $31.26 $31.81 | ▲ +1.76% | ▲ +4.72% | $30.13 (−3.63%) |
May 7, 2026 21w ago | 8-K | $35.88 $39.15 | ▲ +9.11% | ▲ +7.61% | $30.13 (−16.04%) |
Feb 26, 2026 31w ago | 8-K | $42.35 $38.85 | ▼ −8.26% | ▼ −7.14% | $30.13 (−28.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access